胶艾汤抗孕酮撤退致流产的保护作用及机制研究
该研究采用米非司酮诱导孕酮撤退大鼠流产模型,结合斑马鱼血管功能实验与分子模拟,探讨胶艾汤抗先兆流产的药理作用与活性成分。结果显示胶艾汤可减少胚胎丢失、恢复子宫微血管化、改善血液流变学,并上调VEGFA/p-VEGFR2、Integrin β3、LIF、HOXA11等血管与容受性标志物。
要点
- 胶艾汤可减少孕酮撤退大鼠的胚胎丢失并改善子宫微血管化。
- 胶艾汤上调VEGFA/p-VEGFR2、Integrin β3、LIF和HOXA11表达。
- 斑马鱼实验中胶艾汤(12.5-200 μg/mL)促血管生成并减轻出血。
核心结论
- 胶艾汤的抗流产作用与恢复子宫血管稳态、子宫内膜容受性和血液流变学相关。
- 大鼠与斑马鱼模型中均观察到VEGF相关血管生成标志物的相似表达趋势。
研究设计与样本
- 建立米非司酮诱导孕酮撤退的先兆流产大鼠模型,胶艾汤低、中、高剂量分别为6、12、24 g/kg。
- 采用UPLC-Q-TOF-MS/MS鉴定入血与子宫分布成分,并进行分子对接与分子动力学模拟。
- 利用斑马鱼血管损伤、红细胞损伤和出血模型观察胶艾汤的促血管生成与止血效应。
主要发现
- 胶艾汤降低大鼠胚胎丢失率,恢复子宫微血管化(CD31、α-SMA)并改善血液流变学。
- 胶艾汤升高VEGFA/p-VEGFR2、抑制HIF-1α,并增加胎盘血管生成。
- 胶艾汤增加胞饮突密度并上调Integrin β3、LIF、HOXA11,提示子宫内膜容受性改善。
- 分子对接与动力学模拟预测胶艾汤19个主要活性成分与FLT1、VWF靶蛋白稳定结合。
- 斑马鱼中胶艾汤(12.5-200 μg/mL)及腺苷、阿魏酸等成分促血管生成、促红细胞生成并减轻出血。
关键数值与推荐
- 临床原文提及胶艾汤治疗先兆流产有效率超过90%,但未报告具体样本量与统计值。
- 大鼠胶艾汤给药剂量为6、12、24 g/kg。
- 斑马鱼实验胶艾汤浓度范围为12.5-200 μg/mL。
临床怎么用
- 胶艾汤传统用于月经过多、流产后出血及先兆流产,本研究为其孕期维持应用提供实验依据。
- 机制上可关注胶艾汤对子宫血管稳态与子宫内膜容受性的调节作用。
局限性
- 原文未报告临床随机对照试验数据,有效率超过90%为临床观察性描述。
- 分子对接与动力学模拟为预测性结果,尚需实验验证核心成分与靶点的直接结合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Jiao-Ai Decoction (JAD), a classic Traditional Chinese Medicine (TCM) formula, has been applied traditionally for treating gynecological conditions such as menorrhagia, post-abortion bleeding, and threatened abortion (TA). Clinically, it yields an efficacy rate of over 90% for TA treatment, yet its associated molecular events have not been characterized. AIM OF THE STUDY: To explore the pharmacology and bioactive constituents of JAD against TA, focusing on angiogenesis, endometrial receptivity and hemodynamics, using three complementary platforms: rat in vivo models, zebrafish vascular functional assays, and in silico molecular binding prediction. MATERIALS AND METHODS: A mifepristone-induced progesterone withdrawal TA rat model was established, and rats were treated with JAD at either low, medium, or high doses (6, 12, 24 g/kg). Uterine morphology, embryo loss rate, blood viscosity, and histopathology (H&E staining, immunohistochemistry, immunofluorescence) were assessed. Angiogenic (VEGFA, p-VEGFR2, HIF-1α) and receptivity markers (Integrin β3, LIF, HOXA11) were evaluated by western blot and RT-qPCR. UPLC-Q-TOF-MS/MS was used to identify components distributed in blood and uterus. Molecular docking and molecular dynamics were performed to predict potential binding affinity between core bioactive components and vascular-related target proteins. Zebrafish models (vascular injury, erythrocyte injury and hemorrhage) were utilized to observe pro-angiogenic and hemostatic effects of JAD. RESULTS: JAD reduced embryo loss, restored uterine microvascularization (CD31, α-SMA) and improved hemorheology in rats. These phenotypic changes coincided with elevated VEGFA/p-VEGFR2, suppressed HIF-1α and greater placental angiogenesis. Meanwhile, higher pinopod density and upregulated Integrin β3, LIF, and HOXA11 collectively indicated improved endometrial receptivity after treatment. Molecular docking and molecular dynamics simulations predicted stable binding interactions between 19 major bioactive components of JAD and target proteins FLT1 and VWF. In zebrafish, JAD (12.5-200 μg/mL) and its representative constituents (e.g., adenosine, ferulic acid) stimulated angiogenesis and erythropoiesis while mitigating hemorrhage, correlating with elevated VEGFA/p-VEGFR2 protein and vascular-related mRNA levels (vwf, vegfa, flt1, kdr, kdrl). CONCLUSIONS: The anti-abortive effects of JAD are associated with the restoration of uterine vascular homeostasis, endometrial receptivity and hemodynamics. Similar expression trends of VEGF-related angiogenic markers were observed in both rat and zebrafish models after JAD treatment. This work provides experimental evidence linking the traditional use of JAD for pregnancy maintenance to the restoration of uterine vascular homeostasis, thereby bridging classical TCM theory with modern pharmacological insights for mechanistic interpretation.
引用
- Hu X, Yun J, Deng J, et al. Protective effects of Jiao-Ai Decoction against progesterone withdrawal-induced pregnancy loss: Insights from rat model assays, bioactive component analysis, molecular simulation, and zebrafish angiogenesis evaluation. J Ethnopharmacol. 2026. PMID: 42580542. doi:10.1016/j.jep.2026.122290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。